Market Overview

Bill Carpenter to Retire as Chairman and CEO of LifePoint Health; President and COO David Dill to Become CEO

Share:

LifePoint Health (NASDAQ:LPNT) and its Board of Directors announced
today that current Chairman and Chief Executive Officer (CEO) William F.
Carpenter III (Bill) will retire upon completion of the Company's
pending merger with RCCH HealthCare Partners, which is anticipated to
occur later this year. Following his retirement, Carpenter will join the
merged organization's Board of Directors. David Dill, the Company's
current president and chief operating officer (COO), will assume the
role of CEO for LifePoint upon Carpenter's retirement.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180926005284/en/

LifePoint Health Chairman and Chief Executive Officer William F. (Bill) Carpenter III

LifePoint Health Chairman and Chief Executive Officer William F. (Bill) Carpenter III

Carpenter has served as CEO since 2006 and was appointed the additional
position as chairman of the Board in 2010. He is a founding employee of
LifePoint, which was established in 1999. Carpenter led the strategic
process that resulted in the transaction that will merge LifePoint with
RCCH HealthCare Partners and transition LifePoint to a privately-held
company.

"It has been an absolute privilege to lead LifePoint for nearly 13
years, and to be a part of the team since the company's inception almost
20 years ago. I am incredibly proud of all the organization has
accomplished during that time," said Carpenter. "We've grown from 23
hospitals in 9 states, to nearly 70 hospitals in 22 states today, to a
footprint that will soon span coast to coast, pending completion of our
merger with RCCH HealthCare Partners. We've forged partnerships and
innovations within the industry that were first of their kind, such as
being the only investor-owned system selected by CMS to participate in
the Partnership for Patients initiative as a Hospital Engagement
Network, and our joint venture partnership with Duke University Health
System, Duke LifePoint Healthcare. With David's leadership, I'm
confident that LifePoint will continue to advance its mission of Making
Communities Healthier in even more remarkable ways. I cannot think of a
better leader to take LifePoint into the future and am pleased to have
the opportunity to stay engaged through my participation on the Board."

Dill joined LifePoint as executive vice president and chief financial
officer in 2007. He was named COO in 2009 and appointed president and
COO in 2011. Under Dill's leadership, the Company grew its revenues from
$2.6 billion in 2007 to more than $6 billion projected for 2018 and
enhanced quality and patient safety across its hospitals, most notably
by launching the Company's National Quality Program in collaboration
with Duke University Health System.

"It is a tremendous honor to be named CEO of LifePoint Health. When I
joined this organization more than 10 years ago, I was attracted to the
mission – Making Communities Healthier. Today, I continue to be
energized by our mission and the potential to make a positive impact in
communities across the country. I thank and commend Bill for his years
of leadership," remarked Dill. "I believe that LifePoint is better
positioned than ever to be the leader in non-urban healthcare, and to
help define what the delivery of community-based healthcare looks like
in the future. I am fortunate to be surrounded by one of the most
talented teams in the industry that will help take us there.
Additionally, I am excited about the opportunity to work with the team
at RCCH HealthCare Partners as we embark on the next chapter for the
combined company."

Dill will be the first CEO of the merged LifePoint and RCCH HealthCare
organization, which will operate under the LifePoint Health name.
Following the close of the transaction, LifePoint will operate a
diversified portfolio of healthcare assets, including approximately 85
non-urban hospitals in 30 states, regional health systems, physician
practices, outpatient centers and post-acute service providers, with
leading market positions as the sole community healthcare provider in
the majority of the regions it serves.

About LifePoint Health

LifePoint Health® is a leading healthcare company dedicated to Making
Communities Healthier®. Through its subsidiaries, it provides quality
inpatient, outpatient and post-acute services close to home. LifePoint
owns and operates community hospitals, regional health systems,
physician practices, outpatient centers, and post-acute facilities in 22
states. It is the sole community healthcare provider in the majority of
the non-urban communities it serves. More information about the Company
can be found at www.LifePointHealth.net.
All references to "LifePoint," "LifePoint Health" or the "Company" used
in this release refer to affiliates or subsidiaries of LifePoint Health,
Inc.

Additional Information and Where to Find It

This communication relates to the proposed merger transaction involving
LifePoint. In connection with the proposed merger, LifePoint has filed a
preliminary proxy statement and will file a definitive proxy statement
and other relevant documents with the Securities and Exchange Commission
(the "SEC"). This communication is not a substitute for the proxy
statement or any other document that LifePoint may file with the SEC or
send to its stockholders in connection with the proposed merger. BEFORE
MAKING ANY VOTING DECISION, STOCKHOLDERS OF LIFEPOINT ARE URGED TO READ
ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE PROXY
STATEMENT, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and
security holders will be able to obtain the proxy statement and other
documents filed by LifePoint with the SEC (when available) free of
charge at the SEC's website, http://www.sec.gov,
and LifePoint's website, www.lifepointhealth.net.

Participants in the Solicitation

LifePoint and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from the holders of
LifePoint common stock in respect of the proposed transaction.
Information about the directors and executive officers of LifePoint is
set forth in LifePoint's Annual Report on Form 10-K for the year ended
December 31, 2017, filed with the SEC on February 23, 2018, and proxy
statement for its 2018 annual meeting of stockholders, filed with the
SEC on April 25, 2018. Additional information regarding potential
participants in the proxy solicitation and a description of their direct
and indirect interests, by security holdings or otherwise, will be
contained in the proxy statement and other relevant documents to be
filed by LifePoint with the SEC in respect of the proposed transaction.

Forward-Looking Statements

This communication contains certain information, including statements as
to the expected timing, completion and effects of the proposed merger
involving LifePoint, which may constitute forward-looking statements
within the meaning of the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements are subject to risks and uncertainties, and actual results
may differ materially. Such forward looking statements include, among
others, statements about the benefits of the proposed transaction,
including future financial and operating results, plans, objectives,
expectations for LifePoint and other statements that are not historical
facts. Such statements are based on the current beliefs and expectations
of the management of LifePoint and are subject to significant risks and
uncertainties outside of LifePoint's control. These risks and
uncertainties include the possibility that the anticipated benefits from
the proposed transaction will not be realized, or will not be realized
within the expected time periods; the occurrence of any event, change or
other circumstances that could give rise to termination of the proposed
transaction agreement; the failure of LifePoint's stockholders to adopt
the merger agreement; operating costs, loss and business disruption
(including, without limitation, difficulties in maintaining
relationships with employees, customers or suppliers) may be greater
than expected following the announcement of the proposed transaction;
the retention of certain key employees at LifePoint; risks associated
with the disruption of management's attention from ongoing business
operations due to the proposed transaction; the inability to obtain
necessary regulatory approvals of the proposed transaction or the
receipt of such approvals subject to conditions that are not
anticipated; the risk that a condition to closing the transaction may
not be satisfied on a timely basis or at all; the risk that the proposed
transaction fails to close for any other reason; the outcome of any
legal proceedings related to the proposed transaction; the parties'
ability to meet expectations regarding the timing and completion of the
proposed transaction; the impact of the proposed transaction on
LifePoint's credit rating; and other risks described in LifePoint's
Form 10- K, Form 10-Q and Form 8-K reports filed with the SEC. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. Except as otherwise
required by law, LifePoint does not undertake any obligation, and
expressly disclaims any obligation, to update, alter or otherwise revise
any forward-looking statements, whether written or oral, that may be
made from time to time, whether as a result of new information, future
events or otherwise.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com